An important question in virology is the mechanism(s) by which persistent viruses such as the herpesviruses and human immunodeficiency virus (HIV) establish a latent infection in specific types of cells. In the case of herpesviruses, herpes simplex virus (HSV) infection of epithelial cells results in a lytic infection, whereas latent infection is established in sensory neurons. Recent studies have shown the importance of chromatin structure in the regulation of latent infection for both HSV and HIV. For HSV, we have shown previously that the viral latency-associated transcript (LAT) promotes lytic gene silencing and the association of one heterochromatin marker, dimethylation of lysine 9 on histone H3 (H3K9me2), with viral lytic genes. In this study, we further defined the structure of latent viral chromatin by examining the heterochromatin markers on histones associated with the HSV latent genome. We detected the H3K9me2, H3K9me3, and H3K27me3 modifications, with H3K27me3, which is indicative of facultative heterochromatin, exhibiting the highest enrichment on all viral promoters tested. A modification associated with cellular centromeric heterochromatin, H4K20me3, was not detected. A mutant virus containing a 1.8-kbp deletion within the LAT region showed reduced levels of the facultative heterochromatin marker (H3K27me3) along with H3K9me3 during latency, whereas a viral mutant defective for the LAT promoter showed a specific reduction in H3K27me3. Cellular long, noncoding RNAs induce facultative heterochromatin, and this study shows that transcription of a viral noncoding RNA can also induce facultative heterochromatin to promote lytic gene silencing during latency.
Reservoirs of persisting virus in the form of latent infection present a challenge to virus eradication due to their resistance to current antiviral therapies. In the case of human immunodeficiency virus (HIV), deactivation of an infected T cell results in silencing of viral gene expression and entry into a quiescent state (56) . Herpes simplex virus 1 and 2 (HSV-1 and -2) establish a latent infection within sensory ganglia, in which the lytic genes are silenced, and the only viral gene products detected at high levels are a family of noncoding RNAs collectively referred to as the latency-associated transcripts (LATs) (25, 46) . The mechanism(s) by which viral genes are silenced during latent infection and how silencing is overcome to result in virus reactivation are not clear. Given that viral reactivation can result in recurrent infection and transmission to a new host, a greater understanding of the molecular mechanisms that regulate gene expression during latency could potentially yield new therapies.
A proposed mechanism of lytic gene silencing for both HIV and HSV is the association of heterochromatin with the viral genomes (18, 23, 33) . In the case of HSV-1, high levels of histones accumulate on lytic promoters during the establishment of latency (14, 55) , and the histones present are hypoacetylated (27) and enriched for the heterochromatin marker histone H3 dimethyl-lysine 9 (H3K9me2) (55) . The mechanism(s) by which the chromatin structure on lytic promoters is regulated within neurons is not understood, although key viral candidates are the LATs. The most abundant LAT species are 2-kb and 1.5-kb stable introns (19, 44, 54) , which are processed from a primary 8.3-kb LAT transcript that is expressed from a neuron-specific promoter/enhancer (2, 4, 30, 61) . Micro-RNAs have also been detected within the LAT region (13, 49, 53) . The LATs have been found to promote the downregulation of lytic gene expression (9, 20, 31) , and a recent study identified a role for the LATs in promoting the H3K9me2 modification on lytic promoters (55) , suggesting a role for the LATs in the assembly of heterochromatin on lytic promoters.
To determine the mechanism(s) by which LATs promote heterochromatin formation on lytic promoters, it is important to determine the nature of the heterochromatin on the latent genome. Heterochromatin has been divided into two general types: constitutive and facultative (cHC and fHC, respectively). cHC is used to define regions of heterochromatin that are consistently found in all cell types, whereas fHC is transcriptionally silent but has the capacity to convert into euchromatin to allow active gene expression (52) . fHC has been distinguished from cHC on the basis of differential methylation patterns on the core histone proteins. For example, regions of fHC generally contain high levels of H3K9me2, H3K27me3, and H4K20me, whereas cHC contains H3K9me2, H3K9me3, and H4K20me3 (52) . The mechanism by which these different types of modifications are targeted to specific genomic regions is not fully understood, although there is evidence that noncoding RNAs play a role in the targeting of fHC and cHC (59) .
To determine the mechanism by which heterochromatin associates with the HSV-1 genome during latency, it was necessary to further define the structure of latent viral chromatin. By performing chromatin immunoprecipitations (ChIPs) on latently infected ganglia, we have found high levels of H3K27me3, a hallmark of cellular fHC, on the latent viral genome. Furthermore, by carrying out infections with viruses with mutations in the LAT region of the genome, we have identified a role for transcription of the LATs in promoting fHC formation on lytic promoters.
Quantification of relative LAT expression. TG were removed from mice infected with KOS⌬PstLAT or KOS⌬PstR at 30 days postinfection, frozen immediately in liquid nitrogen, and stored at Ϫ80°C. TG were homogenized using glass homogenizers in 1 ml of TRI reagent (Ambion), and the RNA was extracted according to the manufacturer's instructions. Any contaminating DNA was removed by treatment with DNA-free reagent (Ambion), and reverse transcription (RT) was carried out on 200 ng of RNA using the high-capacity cDNA reverse transcription kit (Applied Biosystems). Control reactions in which the reverse transcriptase was omitted were also carried out. The resulting cDNA was quantified by real-time PCR using the power SYBR green PCR master mix and an ABI Prism 7300 sequence detection system (Applied Biosystems), according to the manufacturer's instructions, and compared to a standard curve generated by 10-fold dilutions of cDNA. The final reaction volume was 20 l, containing 2 l of cDNA and 100 nM of each primer. The primers used were as follows: LAT forward, 5Ј-TGTGTGGTGCCCGTGTCTT-3Ј; LAT reverse, 5Ј-CCAGCCAAT CCGTGTCGG-3Ј; mouse GAPDH forward, 5Ј-CTGACGTGCCGCCTGGA GAAA C-3Ј; and mouse GAPDH reverse, 5Ј-CCCGGCATCGAAGGTGGAA GAGT-3Ј. Relative levels of LAT expression were determined by normalizing first to the relative copy number of GAPDH and then to RNA extracted from a KOS⌬PstLAT-infected mouse.
RESULTS
Histone modifications indicative of facultative heterochromatin are associated with viral lytic promoters during latent infection. We had shown that the HSV lytic gene promoters are enriched for histones containing the H3K9me2 modification during latent infection (55) . The goal of this study was to further define the types of heterochromatin on lytic promoters and to investigate the mechanism by which heterochromatin forms on lytic promoters. To this end, we infected mice with WT HSV-1 and performed ChIP on latently infected TG. Immunoprecipitations were carried out using antibodies specific for H3K9me2, H3K9me3, H3K27me3, or H4K20me3. The fraction of DNA immunoprecipitated with each antibody compared to the input was determined by real-time PCR. The levels of heterochromatin on two immediate-early gene (ICP4 and ICP27) promoters along with an early gene (ICP8) promoter were investigated.
In agreement with previous findings, we detected the H3K9me2 modification on all three viral promoters tested, at levels that were enriched above the nonspecific antibody (rabbit immunoglobulin G) control (Fig. 1A to C) . In addition, both H3K9me3 and H3K27me3 modifications were enriched on all three viral promoters tested. However, little viral DNA immunoprecipitated with an H4K20me3-specific antibody as compared to the nonspecific antibody control, suggesting that this modification was not present on chromatin associated with the viral promoters tested. By comparison with the cellular GAPDH control, the relative fraction of viral DNA associated with H3K27me3 was increased compared to H3K9me2 and H3K9me3 on all three viral promoters tested (Fig. 1D to F) , arguing that higher levels of H3K27me3 than H3K9me2 and H3K9me3 were associated with lytic promoters.
To ensure that the lack of immunoprecipitation of HSV-1 promoter sequences by the antibody specific for H4K20me3 was truly due to lack of the H4K20me3 modification, we examined the chromatin associated with cellular centromere sequences, known to be associated with cHC (43) . Analysis of the cellular DNA immunoprecipitated with the various antibodies demonstrated that the H3K9me2, H3K9me3, and H4K20me3 modifications were enriched at the centromeric sequences, but there was little to no H3K27me3 compared to the no-antibody control ( Fig. 2A) . In comparison to the fraction of GAPDH DNA immunoprecipitated, both H3K9me3 and H4K20me3 were highly enriched in centromeric heterochromatin, indicating that the antibodies used were capable of immunoprecipitating cHC (Fig. 2B) . Given the low level of enrichment of H3K27me3 and high level of H4K20me3 on centromeric heterochromatin, the chromatin composition of the latent HSV-1 genome did not resemble cellular centromeric heterochromatin.
Histone modifications associated with the LAT transcriptional unit during latent infection. Previous studies had indicated that within the LAT transcriptional unit, the promoter and the 5Ј exon/enhancer are associated with histones bearing markers of euchromatin, namely acetylated histone H3 lysines 9 and 18, with the 5Ј exon/enhancer having the highest level of enrichment (26, 27) . A region downstream of the 5Ј exon within the region encoding the LAT intron termed CTRL2 (Fig. 3A) had been shown to be bound by the insulator protein CTCF during latency and to possess insulator activities in vitro (1) . Because little is known about the heterochromatin in the LAT region, we were interested to determine whether heterochromatin could be detected on specific regions of the LAT transcriptional unit (Fig. 3A) .
To investigate the levels and types of heterochromatin on the LAT promoter, 5Ј exon/enhancer, and a region downstream of the CTRL2 insulator (Fig. 3C) , we performed ChIP analysis on TG isolated from mice latently infected with HSV-1. As observed for the lytic genes, H3K9me2, H3K9me3, and H3K27me3 were all enriched above the no-antibody control on the region downstream of CTRL2, whereas H4K20me3 was not enriched above the no-antibody control (data not shown). In comparison to the levels present on the GAPDH promoter, the H3K27me3 modifications were detected to the highest level (Fig. 3D ). Lower levels of heterochromatin markers were detected on the LAT 5Ј exon/enhancer, which is consistent with the previous observation that this region is enriched for acetylated histone H3 during latency (26, 27) . The LAT promoter region was associated with histones bearing the H3K27me3 modification characteristic of fHC.
The presence of histone modifications associated with het-
Histone modifications in chromatin on HSV-1 lytic gene promoters during latent infection. ChIP analyses were conducted on TG tissue from mice latently infected with WT HSV-1. The fraction of viral DNA immunoprecipitated with the relevant antibody (ab) was compared to the input value and was expressed as enrichment (fold) compared to the fraction of viral DNA immunoprecipitated by a nonspecific antibody (A to C) or the enrichment over the fraction of GAPDH DNA immunoprecipitated in the same reaction (D to F). Primers were specific for the ICP4 (A and D), ICP27 (B and E), or ICP8 (C and F) gene promoters. The means and standard errors of the means from at least four independent ChIP assays from three independent infections are shown.
FIG. 2. Histone modifications on mouse centromeric heterochromatin.
ChIP analyses were conducted using TG tissue from mice latently infected with HSV-1. The fraction of mouse centromeric heterochromatin immunoprecipitated with the relevant antibody (ab) was determined by real-time PCR and compared to the fraction of centromeric DNA immunoprecipitated by a nonspecific antibody (A) or as the enrichment (fold) over the fraction of GAPDH DNA immunoprecipitated in the same reaction (B). The means and standard errors of the means from at least four independent ChIP assays from three independent infections are shown.
erochromatin on the LAT promoter was surprising, as previous studies had indicated that the LAT promoter is enriched for modifications associated with euchromatin, albeit to lower levels than the 5Ј exon (26, 27) . Therefore, we investigated whether we could also detect markers of euchromatin on the LAT promoter at higher levels than a lytic promoter (ICP4). Because modifications associated with euchromatin had been found at the highest levels downstream of the LAT transcriptional start site, we also investigated a comparable region downstream of the ICP4 gene start site. ChIP analysis was carried out using an antibody against H3K4me3, a marker of both active and poised gene expression (35) , and the relative enrichment of viral DNA was normalized to the enrichment of cellular GAPDH DNA. The GAPDH promoter was not enriched for the H3K4me3 modification compared to the nonspecific antibody control in either chromatin isolated from TG or chromatin prepared from HeLa cells (data not shown). Therefore, the enrichment of all viral DNA was either similar to or higher than that for GAPDH. H3K4me3 was enriched on the 5Ј exon/enhancer ( servations (26, 27) . H3K4me3 was also enriched on the LAT promoter and region downstream of the CTRL2 insulator, although at lower levels than on the 5Ј exon/enhancer (ϳ5-fold and 1.7-fold lower, respectively) (Fig. 4A) . Levels of H3K4me3 on the ICP4 promoter, start site and 5Ј untranslated region were lower than those in the LAT region (ϳ20-, 10-, and 30-fold, respectively) (Fig. 4B) , and the levels of ICP4 DNA immunoprecipitated were similar to those immunoprecipitated with a nonspecific antibody control (data not shown). Therefore, we could detect the H3K4me3 modifications on the LAT promoter at higher levels than on the ICP4 gene promoter.
Hence, it appears that both H3K27me3 and H3K4me3 associate with the LAT promoter. Levels of H3K9me3 and H3K27me3 on lytic promoters are decreased in the absence of the LATs. We had shown a role for the LATs in promoting heterochromatin formation on lytic promoters in the form of H3K9me2 (55) . To investigate whether the LATs play a role in promoting specific histone modifications on lytic promoters during latency, we conducted ChIP analysis on TG isolated from mice latently infected with a LAT deletion virus (KdlLAT) (Fig. 3B) or with the rescued virus (KFSLAT). The KdlLAT virus contains a 1.8-kbp deletion encompassing the LAT promoter, 5Ј exon, and 947 bp of the stable LAT intron (Fig. 3B) (20, 29) . KFSLAT has the deletion replaced with WT sequences. Consistent with the results with WT virus-infected mice, H4K20me3 was not associated with the lytic promoters that we tested; furthermore, the absence of the LAT had no effect on the levels of H4K20me3 (Fig. 5) . In contrast, the levels of the H3K9me3 modification were decreased on all viral promoters tested in TG from mice infected with KdlLAT compared to KFSLAT (ICP4, P ϭ 0.04; ICP27, P ϭ 0.03; ICP8, P ϭ 0.03 [Wilcoxon's signed-rank test]).
Combining the results for all the promoters tested, we observed an average of 1.8-fold more viral DNA associated with H3K9me3 on the KFSLAT genome than on the KdlLAT genome.
Levels of H3K27me3 were also decreased on all of the promoters tested in ganglia from mice infected with KdlLAT virus compared with ganglia infected with KFSLAT virus (Fig. 5 ) (ICP4, P ϭ 0.03; ICP27, P ϭ 0.03; ICP8, P ϭ 0.03 [Wilcoxon's signed-rank test]). When results from all of the promoters tested were combined, 3.4-fold higher levels of KFSLAT DNA were associated with H3K27me3 than with KdlLAT. In total, these results argued that the relative fraction of lytic gene promoters associated with H3K27me3 was decreased more than that associated with H3K9me3 following infection with the LAT-null virus.
Analysis of a LAT promoter deletion mutant virus. Our previous analyses had utilized a LAT deletion mutant virus lacking the promoter, 5Ј exon, and part of the intron (55) . To test a mutant virus with a more specific effect on LAT expression, we constructed a LAT promoter deletion mutant virus, as described in Materials and Methods, by deleting a 202-bp fragment containing the core LAT promoter from HSV-1 to produce the KOS⌬PstLAT virus (Fig. 3B) . The corresponding rescued virus was also constructed by restoration of the deleted sequences into KOS⌬PstLAT to give the PstRLAT virus.
To determine the effect of the LAT promoter deletion on LAT expression, we infected mice with KOS⌬PstLAT or PstRLAT virus and measured LAT expression by real-time RT-PCR carried out on RNA from TG isolated from latently infected mice. We observed an ϳ1,000-fold decrease in the levels of LAT detected within latently infected TG of mice infected with KOS⌬PstLAT compared to PstRLAT (Fig. 6A) , confirming that the mutant virus was indeed defective for LAT expression during latency. The decreased expression of the LAT from KOS⌬PstLAT was not a result of a decreased latent DNA load, as there was an ϳ3.7-fold increase in the relative levels of DNA isolated from mice latently infected with KOS⌬PstLAT compared to those latently infected with the PstRLAT virus (Fig. 6B) .
We then tested the effect of the mutation on chromatin association with viral lytic gene promoters by ChIP analysis. In ganglia from mice infected with KOS⌬PstLAT, we observed a statistically significant decrease in the fraction of ICP4 and ICP27 promoter DNA sequences associated with H3K27me3 during latency, as compared with TG of mice infected with PstRLAT virus (Fig. 6C and D) (P Ͻ 0.05 by Wilcoxon's signed-rank test). Although there were slightly decreased levels of viral DNA associated with H3K9me2 and H3K9me3 following infection with KOS⌬PstLAT, these differences were not statistically significant (P Ͼ 0.05). Therefore, specific de- letion of the LAT promoter, and hence a reduction in LAT expression, resulted in decreased levels of H3K27me3 on viral lytic gene promoters.
DISCUSSION
We and others had shown previously that mutation of the HSV-1 LAT gene results in elevated lytic gene expression during acute (20) and latent (9) infection and reduced levels of the heterochromatin marker H3K9me2 (55) . In this study, we further defined the structure of the latent viral chromatin by examining the heterochromatin markers on the HSV-1 genome during latency and found that the major heterochromatin modification on the histones was associated with HSV-1 lytic gene promoters is H3K27me3, a marker for cellular fHC. Furthermore, H3K27me3 is reduced on viral lytic gene promoters in ganglionic tissue latently infected with a LAT mutant virus missing the LAT promoter, 5Ј exon, and part of the intron or with a viral mutant lacking only the LAT promoter. Thus, the lack of LAT transcription is the likely cause of the reduced H3K27me3, thus pointing to a possible mechanism for RNA silencing.
fHC is associated with HSV-1 lytic promoters during latent infection. We observed that viral lytic gene promoters are enriched for the H3K9me2/3 and H3K27me3, but not H4K20me3, histone modifications during latent infection. In contrast, cellular centromeric heterochromatin is enriched for the H3K9me3 and H4K20me3, but not H3K27me3, histone modifications. Therefore, the chromatin modifications present on HSV-1 lytic promoters during latency do not resemble cellular centromeric heterochromatin. Because H3K27me3 is found at high levels within regions of fHC and not within cHC, these results indicate that heterochromatin similar to cellular fHC is associated with lytic gene promoters during latency.
fHC is defined by its ability to be converted into euchromatin to allow active gene expression. Because HSV-1 must overcome gene silencing for reactivation, it makes sense that viral lytic promoters on at least a portion of viral genomes are assembled into chromatin resembling cellular fHC and not the more stable cHC. However, given the recent discoveries of histone demethylases that are able to remove modifications associated with cHC (22, 57) , it was also possible that the genome was associated with cHC. In addition to H3K27me3, the H3K9me2/3 modifications are also associated with lytic gene promoters, albeit to lower levels than H3K27me3. Although H3K9me3 is classically associated with cHC, it has also been detected within regions of fHC such as the inactive X chromosome (6, 41) . Therefore, it is possible that H3K9me3 is present on histones associated with genomes also bearing the H3K27me3 modification. In the case of HIV latency, the latent viral genome has been found to be associated with H3K9me3 and the heterochromatin HP1 (18, 33) . A recent study also found H3K27me3 to be associated with the latent HIV genome (38) , suggesting a common pattern of histone modifications on latent viral genomes. However, a further possibility is that the two modifications are found on different HSV-1 genomes and potentially different populations of latently infected neurons. Given that populations of neurons have been previously characterized that are positive for HSV-1 DNA but do not express detectable levels of the LAT (10, 34, 39, 42) , it is possible that Histone modifications on the LAT transcriptional unit during latency. The HSV-1 LAT transcriptional unit is the only region of the viral genome that undergoes active transcription during latent infection. Previous studies found that the LAT promoter and 5Ј exon/enhancer region were associated with acetylated histones, a hallmark of euchromatin, with the 5Ј exon/enhancer exhibiting an approximately threefold increase in acetylated histones compared to the promoter (26, 27) . Consistent with its role in maintaining an open chromatin conformation, we also found that the 5Ј exon/enhancer was the only region of the viral genome examined that is not enriched for histone modifications associated with heterochromatin during latency.
Our observation that the LAT promoter is associated with H3K9me3 and H3K27me3 was perhaps surprising given that transcription initiates from the LAT promoter. One possibility is that the dual presence of H3K9me3 and H3K27me3 represents genomes not undergoing active transcription of the LATs. Indeed, a number of studies have found that a large proportion of latently infection neurons do not express detectable levels of the LATs (10, 34, 39, 42) . However, this would imply that even in the absence of active transcription, the 5Ј exon/enhancer does not associate with heterochromatin, whereas the promoter would associate with heterochromatin.
A further possibility is that transcription of the LAT occurs in the presence of heterochromatin on the promoter and is perhaps required for transcription. The LAT promoter appears to be in a bivalent chromatin state, containing markers of both heterochromatin and euchromatin. There is evidence that RNA polymerase II can be recruited to regions containing both the H3K27me3 and H3K4me3 modifications but is blocked from elongating due to the presence of heterochromatin on 5Ј untranslated regions (47) . The presence of euchromatin on the LAT 5Ј exon may therefore allow RNA polymerase II elongation to occur even though H3K27me3 is present on the LAT promoter and would further reinforce the critical role of the 5Ј exon in maintaining long-term expression of the LATs (5, 30) . Furthermore, a requirement of H3K27me3 formation on the Xist promoter during the initiation of X chromosome inactivation has previously been found (48) and may therefore be a common requirement of noncoding RNA transcription in the formation of heterochromatin.
The 5Ј exon/enhancer is separated from nearby lytic promoters by the presence of an insulator element known as CTRL2 (1) . CTRL2 has been identified as an insulator based on the binding of the mammalian insulator protein, CTCF, and its enhancer-blocking activity in vitro (1, 8) . Although CTCF has been found to exhibit enhancer-blocking activities in mammalian cells (3), until recently there was no direct evidence for CTFC in separating active and repressive domains (12) . Our data on the association of heterochromatin with the LAT region further reinforce a potential role for CTCF binding in forming a barrier between the LAT 5Ј exon/enhancer and a region downstream of CTRL2 and hence the ICP0 coding region. However, a modification associated with euchromatin, H3K4me3, was detected downstream of CTRL2. Therefore, our data on the histone modifications on surrounding CTRL2 suggest that it functions to prevent the spreading of heterochromatin from lytic genes onto the LAT 5Ј exon/enhancer but may not confine euchromatin to the LAT 5Ј exon/enhancer.
Comparison of heterochromatin on the KdlLAT and KOS⌬PstLAT genomes. Our previous study found a role for the LATs in promoting H3K9me2 and preventing the euchromatic modification, H3K4me2, on lytic promoters during latency (55). Here we extend those results to conclude that the LAT specifically promotes the formation of fHC. The virus used by Wang et al. was KdlLAT, which contains a 1.8-kb deletion encompassing the LAT promoter, 5Ј exon, and a portion of the CTRL2 insulator (20, 29) . Therefore, although the levels of H3K9me2 (55), H3K9me3, and H3K27me3 were decreased following infection with KdlLAT compared to KFS-LAT, it was possible that deletion of cis-acting DNA sequences and not reduced LAT expression resulted in the reduced heterochromatin formation phenotype. To rule out the possibility that deletion of the 5Ј exon/enhancer and the insulator caused the decreased heterochromatin on lytic promoters following infection with KdlLAT, we constructed a LAT promoter deletion virus, KOS⌬PstLAT. From our experiments with KOS⌬PstLAT, we have identified a clear role for the LATs in promoting H3K27me3 formation on lytic promoters during latency. These results provide the strongest connection to date between LAT transcription and heterochromatin on viral lytic gene promoters.
Additional sequences deleted from the KdlLAT genome but not the KOS⌬PstLAT genome may have affected the levels of H3K9me2/3 on lytic promoters. The deletion in KdlLAT encompasses the 5Ј exon and a portion of the CTRL2 insulator. It seems unlikely that deletion of the 5Ј exon resulted in the increase in H3K9me2/3 formation on lytic promoters as this is the only region of the genome that we found to be depleted of markers associated with heterochromatin and has been found to be enriched for markers of euchromatin (26) . Although we failed to detect clear insulator function for CTRL2 in confining euchromatin to the 5Ј exon/enhancer, it is still possible that deletion of a portion of the CTRL2 insulator resulted in decreased H3K9me3 formation on lytic promoters. Furthermore, insulators can function to mediate long-range genomic interactions (32, 45, 58) . Hence, deletion of a portion of CTRL2 could disrupt any long-range interactions within the HSV-1 genome to reduce heterochromatin association.
Role for LAT noncoding RNA in promoting fHC formation. Although potential open reading frames have been detected within the LAT transcriptional unit (7, 51) , no LAT-encoded protein product has been reliably detected within latently infected neurons (16, 17) . Furthermore, the nucleotide sequence of the LAT region of different HSV-1 strains has been reported to be more highly conserved than the predicted amino acid sequences (7) . Therefore, it is likely that the LATs function as noncoding RNAs, in this case, to promote fHC on the viral genome. Noncoding RNAs are emerging as cofactors in the targeting of fHC formation. In the case of the inactive X chromosome, the Xist RNA has been known for some time to play a role in the induction of gene silencing (37) . Recently an additional RNA also encoded from the Xist locus, termed RepA, was identified (60) . RepA has been found to interact with the polycomb repressor complex 2 (PRC2), which contains a histone methyltransferase responsible for the H3K27me3 modification, and target it to the inactive X chromosome.
RepA is not unique among the noncoding RNAs in binding to PRC2. Noncoding RNAs have been identified that are required for fHC formation on the Hox D locus (HOTAIR) (40) and the Kcnq1 imprinted domain (Kcnq1ot1) (36) . Both the HOTAIR and Kcnq1ot1 RNAs have been found to interact with PRC2 to target it to DNA. Recruitment of PRC2 through an interaction with RNA may explain why no DNA-binding subunit has been identified within mammalian PRC2. If RNA binding is the key mechanism utilized by PRC2 to target it to DNA, then it is possible that though interacting with the LAT RNA, PRC2 is targeted to viral promoters to result in H3K27me3 methylation.
To date, the noncoding RNAs identified as interacting with PRC2 to target it to chromatin are all over 2 kb in length (36, 40, 60) , which would be in keeping with a role for the LAT intron or primary transcript in the initiation of fHC formation. Nevertheless, a role for the microRNAs within the LAT region cannot be ruled out, especially given that an endogenously expressed mammalian microRNA capable of targeting H3K27me3 has recently been identified (21); however, the binding of PRC2 to microRNAs has not been investigated. Regardless of the nature of the exact RNA species within the LAT region required for the fHC target, these results provide further evidence of the role of RNAs of both mammalian and viral origin as cofactors for fHC formation.
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